About Genoll
A multidisciplinary team advancing precision diagnostics, focused on earlier pancreatic cancer detection.
Genoll is built around a pancreatic-first mission: improving molecular signal detection, reducing diagnostic delay, and supporting clinician-reviewable insights through blood-based molecular analysis.
Operational Core
Three pillars of operation.
We pair computational work with diagnostic discipline, operational quality practices, and clinical input.
Pillar 01
Computational Biology
Genomics expertise driving model architecture and multi-omics integration.
Pillar 02
Diagnostics Discipline
Quality-managed diagnostic practices help keep biobanking and assay protocols disciplined.
Pillar 03
Translational Clinical Bridging
Active operations in Coimbatore, India, bridging diagnostics and translation.
Structured View
Grounded in operating context.
Genoll’s work is shaped around India-relevant diagnostic evidence and pancreatic-first molecular signal development, grounded in real hospital workflows and cohort context.
- India-Focused Operating Context
- Scientific and Clinical Leadership
- Hospital and Research Partner Engagement
Focused on the earlier diagnostic window.
By the time pancreatic cancer is diagnosed, clinical options are often already narrow. Genoll’s work focuses on the earlier window, where molecular signal analysis may support more timely clinical review and confirmatory workup.
Operational Vision
Genoll is building with hospitals, translation research collaborators, and long-term strategic healthcare partners, holding India as our primary operational context and South Asian genomic profiles as our reference anchor. We combine our analytical methods, hospital collaborations, and steady delivery — and avoid overstated commercial claims.
Our Leadership
Built by scientific, clinical, and execution leaders.
Our team brings scientific, pathology, clinical-oncology, and microbiology experience to the pancreatic lead program.
Dr. Vignesh Dhandapani
Founder, Chief Scientific Officer & Science Lead
PhD (South Korea) · 40 publications · 5 patents. Computational oncology and bioinformatics; principal investigator across translational discovery programmes.
Dr. Brindha Chelliappan
Senior Scientist – Microbiology
DST INSPIRE Fellow. ICMR and UGC Funded major projects completed. Development of detection systems for clinical diagnostics and microbiology workflows. ISO/IEC 17025:2017 and ISO 9001:2015 for NABL Lab accreditation and Quality Management System (QMS). Clinical Trials, regulatory and Intellectual property Rights (IPR).
Sahana N
Bioinformatics Associate · Omics Data Analysis
Master’s in Bioinformatics. Works across RNA-seq, microarray analysis, differential expression, pathway enrichment, batch correction, biomarker identification, and omics data interpretation.
Dr. Arun Selvaraju
UK Clinical Advisor (NHS) & Translation Lead
NHS Acute Oncology Lead · 18+ yrs practice. FoundationOne CDx; direct clinical integration and translational review.
Dr. Ramesh Dasarathan
Clinical and Regulatory Advisor & Hospital Bridge
30+ yrs practice · Hospital and regulatory bridge; institutional and translational strategy. Stanley Medical College alumni.
Dr. B. Kesavan
Advisory Board Member
MBBS, MS, MCh (Surgical Gastroenterology). Associate Professor, Government Mohan Kumaramangalam Medical College, Salem · 10 publications. Advises Genoll on the surgical and clinical pathway for pancreatic and GI cancers, and on hospital validation planning.
Somas Kandan
Co-Founder & Growth Strategist
25+ years of entrepreneurial and cross-functional leadership across operations, product, marketing, training, and business growth. Built teams, managed delivery, and scaled initiatives across education, animation, and technology-led environments.
Rajnikanth Srinivasan
Director – IT and Growth Strategist
20 years delivering enterprise technology across banking, telecom and global technology accounts. Leads Genoll's IT, program delivery and growth strategy.
Vikram Visvanathan
Board Member & Strategic Advisor
Translational medtech founder and venture builder in ENT and Ophthalmology (IntraSonus, Lattice MNA). Advises Genoll's board on translational strategy, validation roadmap design, clinical partnerships and the path to regulatory and investor readiness.
Science Core
Discover the science driving our programs.
Learn about our multi-omics detection layers, signal analysis model, and sequencing quality baseline.